Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...
As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...
About 1.9 million young women had HIV in 2023 due to gender inequality, poverty, and discrimination The dapivirine ring and dual prevention pill offer new protection options for women New tools ...
In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...
Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...
See privacy policy. [LIMA, PERU] Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has proven highly effective in human trials, ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
In a groundbreaking development for HIV prevention, the efficacy and safety of a six-monthly injection containing the antiretroviral drug lenacapavir have been confirmed through two pivotal studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback